Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes

AIMS: Gliclazide pharmacokinetics and pharmacodynamics were assessed in 9 Caucasians and 10 Australian Aborigines with uncomplicated type 2 diabetes. METHODS: Subjects were on a stable dose of 80 mg gliclazide twice daily, took 160 mg on the morning of study and had a standard breakfast. No further...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Davis, Timothy M E, Daly, Frank, Walsh, John P, Ilett, Kenneth F, Beilby, John P, Dusci, Leon J, Barrett, P Hugh R
Формат: Artigo
Язык:Inglês
Опубликовано: Blackwell Science Inc 2000
Предметы:
Pharmacokinetics/Pharmacodynamics
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2014921/
https://ncbi.nlm.nih.gov/pubmed/10718777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.2000.00162.x
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы